Sai Silks (Kalamandir) Ratios

Sai Silks (Kalamandir) Ltd Ratios

The Sai Silks (Kalamandir) Ltd Ratios page provides a complete fundamental analysis of Sai Silks (Kalamandir) Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Sai Silks (Kalamandir) Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Sai Silks (Kalamandir) Ltd (NSE: KALAMANDIR, BSE: 543989) is currently trading at ₹112.94, with a market capitalization of ₹17.27B. As a major player in the Retail trade sector and Apparel/Footwear retail industry, Sai Silks (Kalamandir) Ltd remains a key stock for fundamental analysis using Sai Silks (Kalamandir) Ltd Ratios.

Sai Silks (Kalamandir) Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Sai Silks (Kalamandir) Ltd P/E ratio currently stands at 22.78, making it one of the most tracked metrics in Sai Silks (Kalamandir) Ltd Ratios.

Historically, the Sai Silks (Kalamandir) Ltd P/E ratio has shown strong fluctuations:

• 2024: 22.78
• 2023: 26.68
• 2022: 0
• 2021: 0
• 2020: 0

The decline in Sai Silks (Kalamandir) Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Sai Silks (Kalamandir) Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 1.72.

Historical P/B trend:

• 2024: 1.72
• 2023: 2.78
• 2022: 0
• 2021: 0

Sai Silks (Kalamandir) Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Sai Silks (Kalamandir) Ltd P/S ratio currently stands at 1.33, an important part of Sai Silks (Kalamandir) Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 1.33
• 2023: 1.96
• 2022: 0
• 2021: 0

A stable or declining Sai Silks (Kalamandir) Ltd P/S ratio indicates cautious market sentiment.

Sai Silks (Kalamandir) Ltd Price to Cash Flow Ratio (P/CF)

The Sai Silks (Kalamandir) Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 22.89.

Historical Sai Silks (Kalamandir) Ltd Price to Cash Flow Ratio:

• 2024: 22.89
• 2023: 0
• 2022: 0
• 2021: 0
• 2020: 0

The rising Sai Silks (Kalamandir) Ltd Price to Cash Flow Ratio indicates premium valuation based on cash flow.

Sai Silks (Kalamandir) Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Sai Silks (Kalamandir) Ltd EV currently stands at ₹20.55B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 20.55B
• 2023: 27.54B
• 2022: 0
• 2021: 0

Sai Silks (Kalamandir) Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Sai Silks (Kalamandir) Ltd EV/EBITDA ratio is currently 9.31, a key metric in Sai Silks (Kalamandir) Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 9.31
• 2023: 12.45
• 2022: 0
• 2021: 0

Stable Sai Silks (Kalamandir) Ltd EV/EBITDA indicates balanced valuation.

Sai Silks (Kalamandir) Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Sai Silks (Kalamandir) Ltd D/E ratio is currently 0.36, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.36
• 2023: 0.44
• 2022: 1.32
• 2021: 1.24

Sai Silks (Kalamandir) Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Sai Silks (Kalamandir) Ltd ROE currently stands at 7.78%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 7.78
• 2023: 13.82
• 2022: 27.36
• 2021: 18.84

Declining ROE indicates pressure on profitability.

Sai Silks (Kalamandir) Ltd Ratios Analysis Summary

The Sai Silks (Kalamandir) Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Sai Silks (Kalamandir) Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Sai Silks (Kalamandir) Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.